Histamine Antagonists - Administration & dosage
Research News and Information

Tuesday, November 24, 2009

Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activity.

22 Sep 2009 Antagonism of the histamine-H(3) receptor is one tactic being explored to increase wakefulness for the treatment of disorders such as excessive daytime sleepiness (EDS) as well as other sleep or cognitive disorders. Phenethyl-R-2-methylpyrrolidine ... Read more...

Allergic contact dermatitis in children: common allergens and treatment: a review.

30 Jul 2009 PURPOSE OF REVIEW: The following study reviews the recent literature pertaining to allergic contact dermatitis (ACD) in the pediatric population. This study also provides an overview of the most common allergens and discusses various therapeutic ... Read more...

[Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series]

29 Jun 2009 BACKGROUND AND OBJECTIVES: The causal treatment of chronic pruritus is not always possible or effective necessitating symptomatic antipruritic therapy. Antihistamines are the only drugs approved for the treatment of chronic pruritus, but they are ... Read more...

Latest indexed articles for 'Histamine Antagonists - Administration & dosage'

These are the very latest articles for this heading:

• Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activity. 22 Sep 2009
• Allergic contact dermatitis in children: common allergens and treatment: a review. 30 Jul 2009
• [Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series] 29 Jun 2009
• [Effect of preliminary medication on oxaliplatin hypersensitivity] 29 Jun 2009
• [Pollen allergy and pregnancy. A literature review of anti-allergic agents shows no increased risk of fetal injuries] 30 May 2009
• Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. 30 May 2009
• Hand dermatitis: review of etiology, diagnosis, and treatment. 29 Apr 2009
• Minimal and moderate oral sedation in the adult special needs patient. 30 Mar 2009
• Effect of histamine H4 receptor antagonist on allergic rhinitis in mice. 7 Mar 2009
• Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy. 27 Feb 2009
• [Inflammation of the conjunctiva] 27 Feb 2009
• High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. 4 Feb 2009
• [Severe hematogenous contact dermatitis after oral nickel exposition] 30 Jan 2009
• Anaesthesia in patients with mastocytosis. 30 Jan 2009
• Dimenhydrinate-induced fixed drug eruption in a patient who tolerated other antihistamines. 30 Dec 2008
• Therapeutic alternatives in a patient with DRESS syndrome induced by allopurinol. 30 Dec 2008
• Acute urticaria and angioedema: diagnostic and treatment considerations. 30 Dec 2008
• [The specific features of therapy for allergic rhinitis in children] 30 Dec 2008
• [Allergy and vaccination] 30 Dec 2008
• Pharmacokinetic characteristics and safety and tolerability of a reformulated azelastine hydrochloride nasal spray in patients with chronic rhinitis. 30 Dec 2008

See a longer list of these articles.

Technical information about 'Histamine Antagonists'

Definition: Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.

Registry Number: 0

Descriptor UI: D006633

Alternative terms: Histamine Antagonists; Antagonists, Histamine; Antihistamines;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.519.625.375.425; D27.505.696.577.375.425;

History Note: 1977; for ANTIHISTAMINES use HISTAMINE H1 ANTAGONISTS 1997-2008

Technical Notes: GEN or unspecified; prefer specifics; do not confuse with HISTAMINE AGONISTS; DF: HISTAMINE ANTAG